https://www.selleckchem.com/pr....oducts/epibrassinoli
00, 1.09 (0.86-1.39), 1.48 (1.16-1.89); ptrend=0.002] but not with colorectal cancer (p=0.84), although an association [1.00, 0.98 (0.68-1.39), 1.24 (0.88-1.76); ptrend=0.08] was suggested for this cancer after excluding cases that occurred within 7 years of blood draw (pheterogeneity=0.06). CONCLUSIONS The VAT score predicted risks of postmenopausal breast cancer and can be used for risk assessment in diverse populations. IMPACT These findings provide specific evidence for a role of VAT in breast cancer. Copyright ©2020, Americ
お気に入り
コメント
シェア
